Literature DB >> 19544541

Predictive models in palliative care.

Carla Ida Ripamonti1, Gabriella Farina, Marina Chiara Garassino.   

Abstract

It is important to identify prognostic and predictive factors concerning both life expectancy and quality of life in palliative care patients to facilitate ethical, clinical, and organizational decisions, but also to use resources in the best possible way. The authors reviewed the literature to identify the major factors that can predict survival of patients with solid tumors. They found only a few prospective assessments of prognostic factors. Clinical prognostic/predictors of survival based on physician's and/or nurse's judgment, performance status, dyspnea at rest, anorexia, dysphagia, or delirium are all considered to be of primary importance. Despite several contrasting findings, it is generally agreed that the type and site of the primary tumor and metastasis, psychosocial factors, and quality of life should be considered secondary to the organic effects in the final stages of life. Leukocytosis, lymphocytopenia, and elevated C-reactive protein are all reported to have prognostic significance, and low serum albumin and high lactate dehydrogenase levels must also be taken into consideration. Cancer 2009;115(13 suppl):3128-34. (c) 2009 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544541     DOI: 10.1002/cncr.24351

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Swallowing problems at the end of the palliative phase: incidence and severity in 164 unsedated patients.

Authors:  Hans Bogaardt; Laetitia Veerbeek; Katherine Kelly; Agnes van der Heide; Lia van Zuylen; Renée Speyer
Journal:  Dysphagia       Date:  2014-12-23       Impact factor: 3.438

2.  Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China.

Authors:  Yu Huang; Qingsong Xi; Shu Xia; Xushi Wang; Yong Liu; Chao Huang; Wei Zheng; Shiying Yu
Journal:  Support Care Cancer       Date:  2013-09-07       Impact factor: 3.603

3.  Methicillin-resistant Staphylococcus aureus in surgical patients: identification of high-risk populations for the development of targeted screening programmes.

Authors:  Stephanie Fraser; Richard R Brady; Catriona Graham; Simon Paterson-Brown; Alan P Gibb
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

4.  Association of goals of care meetings for hospitalized cancer patients at risk for critical care with patient outcomes.

Authors:  Colleen C Apostol; Julie M Waldfogel; Elizabeth R Pfoh; Donald List; Lynn S Billing; Suzanne A Nesbit; Sydney Morss Dy
Journal:  Palliat Med       Date:  2014-12-19       Impact factor: 4.762

5.  A proposed systems approach to the evaluation of integrated palliative care.

Authors:  Daryl Bainbridge; Kevin Brazil; Paul Krueger; Jenny Ploeg; Alan Taniguchi
Journal:  BMC Palliat Care       Date:  2010-05-10       Impact factor: 3.234

6.  The development of an instrument that can identify children with palliative care needs: the Paediatric Palliative Screening Scale (PaPaS Scale): a qualitative study approach.

Authors:  Eva Bergstraesser; Richard D Hain; José L Pereira
Journal:  BMC Palliat Care       Date:  2013-05-08       Impact factor: 3.234

7.  Validation of the prognosis in palliative care study predictor models in terminal cancer patients.

Authors:  Eun-Shin Kim; Jung-Kwon Lee; Mi-Hyun Kim; Hye-Mi Noh; Yeong-Hyeon Jin
Journal:  Korean J Fam Med       Date:  2014-11-21

8.  Hypocalcemia in cancer patients: An exploratory study.

Authors:  José António Ferraz Gonçalves; Telma Costa; Joana Rema; Cristina Pinto; Miguel Magalhães; Ana Esperança; Luciana Sousa
Journal:  Porto Biomed J       Date:  2019-07-08

9.  Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group.

Authors:  Daniel Habermehl; Ingo C Brecht; Jürgen Debus; Stephanie E Combs
Journal:  Eur J Med Res       Date:  2014-05-13       Impact factor: 2.175

10.  Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.

Authors:  Rujiao Liu; Jun Cao; Xiang Gao; Jian Zhang; Leiping Wang; Biyun Wang; Lin Guo; Xichun Hu; Zhonghua Wang
Journal:  Tumour Biol       Date:  2016-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.